PesoRama Inc.
PSSOF
$0.0951
$0.012915.69%
| Weiss Ratings | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.22 | |||
| Price History | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 15.55% | |||
| 30-Day Total Return | 15.55% | |||
| 60-Day Total Return | 15.55% | |||
| 90-Day Total Return | 15.55% | |||
| Year to Date Total Return | 15.55% | |||
| 1-Year Total Return | 15.55% | |||
| 2-Year Total Return | -36.60% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.10 | |||
| 52-Week Low Price (Date) | Feb 27, 2025 | |||
| 52-Week High Price (Date) | Feb 27, 2025 | |||
| Valuation | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 8.65M | |||
| Enterprise Value | 20.32M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | -14.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.54 | |||
| Price/Book (Q) | -2.21 | |||
| Enterprise Value/Revenue (TTM) | 1.24 | |||
| Price | $0.10 | |||
| Enterprise Value/EBITDA (TTM) | -8.01 | |||
| Enterprise Value/EBIT | -5.32 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 95.86M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 77 King Street West Toronto, ON M5K 1G8 | |||
| Website | www.pesorama.ca | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -23.32% | |||
| Profit Margin | -33.67% | |||
| Management Effectiveness | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -16.72% | |||
| Return on Equity | -- | |||
| Income Statement | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 16.90M | |||
| Total Revenue (TTM) | 16.90M | |||
| Revenue Per Share | $0.18 | |||
| Gross Profit (TTM) | 6.69M | |||
| EBITDA (TTM) | -2.62M | |||
| EBIT (TTM) | -3.94M | |||
| Net Income (TTM) | -5.69M | |||
| Net Income Avl. to Common (TTM) | -5.69M | |||
| Total Revenue Growth (Q YOY) | 3.52% | |||
| Earnings Growth (Q YOY) | 35.27% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | 36.92% | |||
| Balance Sheet | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 514.50K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 9.38M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -4.12M | |||
| Current Ratio (Q) | 1.053 | |||
| Book Value Per Share (Q) | -$0.04 | |||
| Total Assets (Q) | 16.26M | |||
| Total Current Liabilities (Q) | 8.90M | |||
| Total Debt (Q) | 12.59M | |||
| Total Liabilities (Q) | 20.38M | |||
| Total Common Equity (Q) | -4.12M | |||
| Cash Flow | PSSOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -507.80K | |||
| Cash from Financing (TTM) | 2.88M | |||
| Net Change in Cash (TTM) | -1.09M | |||
| Levered Free Cash Flow (TTM) | -2.16M | |||
| Cash from Operations (TTM) | -3.36M | |||
